학술논문

Why Did ZIKV Perinatal Outcomes Differ in Distinct Regions of Brazil? An Exploratory Study of Two Cohorts
Document Type
article
Source
Viruses. 13(5)
Subject
Microbiology
Biological Sciences
Pediatric
Prevention
Vaccine Related
Emerging Infectious Diseases
Perinatal Period - Conditions Originating in Perinatal Period
Biodefense
Infectious Diseases
Aetiology
2.1 Biological and endogenous factors
Infection
Reproductive health and childbirth
Good Health and Well Being
Adult
Antibodies
Viral
Brazil
Cohort Studies
Coinfection
Dengue
Female
Health Impact Assessment
Humans
Infant
Newborn
Male
Middle Aged
Odds Ratio
Pregnancy
Pregnancy Complications
Infectious
Pregnancy Outcome
Prevalence
Public Health Surveillance
Risk Factors
Young Adult
Zika Virus
Zika Virus Infection
Zika
pregnancy
obstetrics
arboviruses
dengue
Language
Abstract
The Zika virus (ZIKV) epidemic in Brazil occurred in regions where dengue viruses (DENV) are historically endemic. We investigated the differences in adverse pregnancy/infant outcomes in two cohorts comprising 114 pregnant women with PCR-confirmed ZIKV infection in Rio de Janeiro, Southeastern Brazil (n = 50) and Manaus, in the north region of the country (n = 64). Prior exposure to DENV was evaluated through plaque reduction neutralizing antibody assays (PRNT 80) and DENV IgG serologies. Potential associations between pregnancy outcomes and Zika attack rates in the two cities were explored. Overall, 31 women (27%) had adverse pregnancy/infant outcomes, 27 in Rio (54%) and 4 in Manaus (6%), p < 0.001. This included 4 pregnancy losses (13%) and 27 infants with abnormalities at birth (24%). A total of 93 women (82%) had evidence of prior DENV exposure, 45 in Rio (90%) and 48 in Manaus (75%). Zika attack rates differed; the rate in Rio was 10.28 cases/10,000 and in Manaus, 0.6 cases/10,000, p < 0.001. Only Zika attack rates (Odds Ratio: 17.6, 95% Confidence Interval 5.6-55.9, p < 0.001) and infection in the first trimester of pregnancy (OR: 4.26, 95% CI 1.4-12.9, p = 0.011) were associated with adverse pregnancy and infant outcomes. Pre-existing immunity to DENV was not associated with outcomes (normal or abnormal) in patients with ZIKV infection during pregnancy.